Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study

BackgroundSARS-CoV-2 vaccination in rheumatoid arthritis (RA) patients treated with B cell-depleting drugs induced limited seroconversion but robust cellular response. We aimed to document specific T and B cell immunity in response to vaccine booster doses and breakthrough infection (BTI).MethodsWe...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, Ingrid M. Egner, Trung The Tran, Lisa Tietze, Katrine Persgård Lund, Anne Therese Tveter, Sella A. Provan, Hilde Ørbo, Espen A. Haavardsholm, John Torgils Vaage, Kristin Jørgensen, Silje Watterdal Syversen, Fridtjof Lund-Johansen, Guro Løvik Goll, Ludvig A. Munthe
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2024-02-01
Serier:	Frontiers in Immunology
Fag:	T cell B cell COVID-19 mRNA vaccination rheumatoid arthritis rituximab
Online adgang:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1296273/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!